Lw-213 Synergizes with Rituximab to Inhibit Diffuse Large B-Cell Lymphomas By Upregulating CD20

被引：0
|
作者：
Li, Yuchen [1 ]
Li, Hui [2 ]
Hui, Hui [1 ]
Xu, Jingyan [3 ]
机构：
[1] China Pharmaceut Univ, Nanjing, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Peoples R China
[3] Nanjing Drum Tower Hosp, Hematol Dept, Nanjing, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
CD20 DLBCL Rituximab SOX2 Histone Deacetylation;
D O I：
10.1182/blood-2021-149515
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4366
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Everolimus in diffuse large B-cell lymphomas
    Merli, Michele
    Ferrario, Andrea
    Maffioli, Margherita
    Arcaini, Luca
    Passamonti, Francesco
    FUTURE ONCOLOGY, 2015, 11 (03) : 373 - 383
  • [32] Treatment of diffuse large B-cell lymphomas
    Fisher, Richard I.
    SEMINARS IN HEMATOLOGY, 2006, 43 (04) : 205 - 206
  • [33] Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy
    Clarke, LE
    Bayerl, MG
    Ehmann, WC
    Helm, KF
    JOURNAL OF CUTANEOUS PATHOLOGY, 2003, 30 (07) : 459 - 462
  • [34] Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma
    Baiyee, Daniel
    Warnke, Roger
    Natkunam, Yasodha
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (02) : 93 - 95
  • [35] Follicular origin of CD5+ diffuse large B-cell lymphomas
    Catherwood, MA
    Venkatraman, L
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (06) : 954 - 955
  • [36] Lacking clonal relationship in 20% of relapsing diffuse large B-cell lymphomas
    Juskevicius, Darius
    Rufle, Alexander
    Ruiz, Christian
    Dirnhofer, Stephan
    Tzankov, Alexandar
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Treatment of CD20+ B-cell cutaneous lymphomas using intralesional rituximab
    Marco, Ardigo
    de Felice, Catia
    Berardesca, Enzo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB7 - AB7
  • [38] Diagnosis and treatment of CD20 negative B cell lymphomas
    Katchi, Tasleem
    Liu, Delong
    BIOMARKER RESEARCH, 2017, 5
  • [39] Diagnosis and treatment of CD20 negative B cell lymphomas
    Tasleem Katchi
    Delong Liu
    Biomarker Research, 5
  • [40] PAX5 immunostaining in the diagnosis of relapsed CD20 negative B-cell non Hodgkins lymphomas after treatment with rituximab
    Narbaitz, M. I.
    Kitagawa, R. B.
    Martin, C. A.
    HISTOPATHOLOGY, 2010, 57 : 152 - 152
12345